Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
5.95
-0.04 (-0.67%)
At close: Apr 28, 2026, 4:00 PM EDT
6.17
+0.22 (3.78%)
Pre-market: Apr 29, 2026, 7:53 AM EDT
Plus Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 41 | 70 | 7 | 8 | 11 | 16 | |
| Market Cap Growth | 221.49% | 938.30% | -14.33% | -25.69% | -33.96% | 67.05% | |
| Enterprise Value | 33 | 60 | 5 | 1 | -4 | 2 | |
| Last Close Price | 5.95 | 12.81 | 28.75 | 43.75 | 118.87 | 393.75 | |
| PS Ratio | 7.83 | 13.51 | 1.16 | 1.61 | 47.55 | - | |
| PB Ratio | 8.26 | 17.62 | -0.76 | -5.87 | 1.65 | 1.49 | |
| P/TBV Ratio | 12.41 | 21.39 | - | - | 1.78 | 1.55 | |
| EV/Sales Ratio | 6.34 | 11.55 | 0.93 | 0.30 | - | - | |
| Debt / Equity Ratio | 0.21 | 0.21 | -0.38 | -3.10 | 0.88 | 0.65 | |
| Net Debt / Equity Ratio | -1.95 | -1.95 | 0.03 | 3.24 | -1.94 | -1.05 | |
| Net Debt / EBITDA Ratio | 0.53 | 0.53 | 0.02 | 0.35 | 0.65 | 0.97 | |
| Net Debt / FCF Ratio | 0.37 | 0.37 | 0.02 | 0.34 | 0.93 | 1.09 | |
| Asset Turnover | 0.45 | 0.45 | 0.65 | 0.28 | 0.01 | - | |
| Quick Ratio | 0.73 | 0.73 | 0.27 | 0.80 | 1.53 | 3.14 | |
| Current Ratio | 1.23 | 1.23 | 0.34 | 0.92 | 1.84 | 3.36 | |
| Return on Equity (ROE) | - | - | - | -522.50% | -234.65% | -193.25% | |
| Return on Assets (ROA) | -83.29% | -83.29% | -101.93% | -47.23% | -53.74% | -44.65% | |
| Return on Capital Employed (ROCE) | -381.40% | -381.40% | 164.80% | -2015.30% | -164.10% | -75.60% | |
| Earnings Yield | -54.83% | -31.80% | -191.39% | -168.24% | -190.35% | -83.08% | |
| FCF Yield | -51.05% | -29.60% | -157.80% | -164.38% | -126.56% | -64.63% | |
| Buyback Yield / Dilution | -910.35% | -910.35% | -145.18% | -79.45% | -117.18% | -173.02% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.